Critical Limb Ischemia clinical trials at UCSD
1 research study open to eligible people
Showing trials for
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
open to eligible people ages 18-95
A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.
La Jolla, California and other locations
Our lead scientists for Critical Limb Ischemia research studies include Ann Gaffey.
Last updated: